Prognostic MRI biomarkers of treatment efficacy for retinopathy

NMR in Biomedicine

Volumn 21, Issue 9, 2008, Pages 957-967

  Berkowitz, Bruce A ^a,b   Roberts, Robin ^b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

Biomarker; Blindness; Diabetes; Retina; Vision

Indexed keywords

ALDEHYDES; EYE PROTECTION; LEAKAGE (FLUID); MANGANESE; OXYGEN;

AUTOREGULATION; BLINDNESS; CLINICAL SETTINGS; CONTRAST AGENTS; DIABETES; OXYGEN LEVELS; OXYGEN TENSIONS; RETINA; SURFACE AREAS; VISION LOSSES; VISUAL TASKS;

BIOMARKERS;

ADENOSINE TRIPHOSPHATE; ALBUMIN; ALDOSE REDUCTASE INHIBITOR; AMINOGUANIDINE; CARBOGEN; CYCLOOXYGENASE 2 INHIBITOR; DILTIAZEM; ENDOTHELIN RECEPTOR ANTAGONIST; EVANS BLUE; FLUORESCEIN; GADOLINIUM PENTETATE; GLUCOSE; LACTIC ACID; MANGANESE; MANGANESE CHLORIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; OXYGEN; PYRUVIC ACID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; RUBOXISTAURIN; THIOCTIC ACID; TRIAMCINOLONE ACETONIDE; VASCULOTROPIN INHIBITOR;

BLOOD RETINA BARRIER; CHOROID MELANOMA; CLINICAL TRIAL; CONTRAST ENHANCEMENT; DIABETIC RETINOPATHY; DRUG DOSE COMPARISON; DRUG EFFICACY; ENDOPHTHALMITIS; FLUORINE NUCLEAR MAGNETIC RESONANCE; GLAUCOMA; HUMAN; INTERMETHOD COMPARISON; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN BLOOD LEVEL; OXYGEN TENSION; PATHOGENESIS; PRIMARY PREVENTION; PRIORITY JOURNAL; PROGNOSIS; PROLIFERATIVE RETINOPATHY; RETINA ARTERY OCCLUSION; RETINA INJURY; RETINITIS PIGMENTOSA; RETINOPATHY; RETROLENTAL FIBROPLASIA; REVIEW; SINGLE DRUG DOSE; THERAPY EFFECT; TREATMENT OUTCOME; VITREORETINOPATHY;

ANIMALS; BIOLOGICAL MARKERS; EYE; EYE DISEASES; HUMANS; MAGNETIC RESONANCE IMAGING; OXYGEN; PROGNOSIS; RETINA; TREATMENT OUTCOME;

EID: 57149134817     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1303     Document Type: Review

References (98)

1. Luan H, Roberts R, Sniegowski M, Goebel DJ, Berkowitz BA. Retinal thickness and subnormal retinal oxygenation response in experimental diabetic retinopathy. Invest Ophthalmol Vis Sci 2006; 47(1): 320-328.
2. Berkowitz BA, Roberts R, Luan H, Peysakhov J, Mao X, Thomas KA. Dynamic contrast-enhanced MRI measurements of passive permeability through blood retinal barrier in diabetic rats. Invest Ophthalmol Vis Sci 2004; 45(7): 2391-2398.
3. Sander B, Thornit DN, Colmorn L, Strom C, Girach A, Hubbard LD, Lund-Andersen H, Larsen M. Progression of diabetic macular edema: correlation with blood retinal barrier permeability, retinal thickness, and retinal vessel diameter. Invest Ophthalmol Vis Sci 2007; 48(9): 3983-3987.
4. Gonzalez RG, Cheng HM, Barnett P, Aguayo J, Glaser B, Rosen B, Burt CT, Brady T. Nuclear magnetic resonance imaging of the vitreous body. Science 1984; 223(4634): 399-400.
5. Frank JA, Dwyer AJ, Girton M, Knop RH, Sank VJ, Gansow OA, Magerstadt M, Brechbiel M, Doppman JL. Opening of blood-ocular barrier demonstrated by contrast-enhanced MR imaging. J. Comput Assist Tomogr 1986; 10(6): 912-916
6. Plehwe WE, McRobbie DW, Lerski RA, Kohner EM. Quantitative magnetic resonance imaging in assessment of the blood-retinal barrier. Invest Ophthalmol Vis Sci 1988; 29(5): 663-670.
7. Berkowitz BA, Wilson CA. Quantitative mapping of ocular oxygenation using magnetic resonance imaging. Magn Reson Med 1995; 33(4): 579-581.
8. Berkowitz BA, Roberts R, Goebel DJ, Luan H. Noninvasive and simultaneous imaging of layer-specific retinal functional adaptation by manganese-enhanced MRI. Invest Ophthalmol Vis Sci 2006; 47(6): 2668-2674.
9. Berkowitz BA, Roberts R, Luan H, Bissig D, Bui BV, Gradianu M, Calkins DJ, Vingrys AJ. Manganese-enhanced MRI studies of alterations of intraretinal ion demand in models of ocular injury. Invest Ophthalmol Vis Sci 2007; 48(8): 3796-3804.
10. Remtulla S, Hallett PE. A schematic eye for the mouse, and comparisons with the rat. Vision Res 1985; 25(1): 21-31.
11. Shen Q, Cheng H, Pardue MT, Chang TF, Nair G, Vo VT, Shonat RD, Duong TQ. Magnetic resonance imaging of tissue and vascular layers in the cat retina. J. Magn Reson Imaging 2006; 23(4): 465-472.
12. Chen J, Wang Q, Zhang H, Yang X, Wang J, Berkowitz BA, Wickline SA, Song SK. In vivo quantification of T1, T2, and apparent diffusion coefficient in the mouse retina at 11.74 T. Magn Reson Med 2008; 59(4): 731-738.
13. Chan KC, Fu QL, So KF, Wu EX. Evaluation of the Visual system in a rat model of chronic glaucoma using manganese-enhanced magnetic resonance imaging. Conf Proc IEEE Eng Med Biol Soc 2007; 1: 67-70.
14. Cheng H, Nair G, Walker TA, Kim MK, Pardue MT, Thule PM, Olson DE, Duong TQ. Structural and functional MRI reveals multiple retinal layers. Proc Natl Acad Sci USA 2006; 103(46): 17525-17530.
15. Li Y, Cheng H, Duong TQ. Blood-flow magnetic resonance imaging of the retina. NeuroImage 2008; 39(4): 1744-1751.
16. Berkowitz BA, Tofts PS, Sen HA, Ando N, de Juan E Jr. Accurate and precise measurement of blood-retinal barrier breakdown using dynamic Gd-DTPA MRI. Invest Ophthalmol Vis Sci 1992; 33(13): 3500-3506.
17. Berkowitz BA, Roberts R, Luan H, Bissig D, Bui BV, Gradianu M, Calkins DJ, Vingrys AJ. Manganese-enhanced MRI studies of alterations of intraretinal ion demand in models of ocular injury. Invest Ophthalmol Vis Sci 2007; 48(8): 3796-3804.
18. Berkowitz BA, Bansal N, Wilson CA. Non-invasive measurement of steady-state vitreous lactate concentration. NMR Biomed 1994; 7(6): 263-268.
19. Berkowitz BA, Garner MH, Wilson CA, Corbett RJ. Nondestructive measurement of retinal glucose transport and consumption in vivo using NMR spectroscopy. J. Neurochem 1995; 64(5): 2325-2331.
20. Berkowitz BA. Adult and newborn rat inner retinal oxygenation during carbogen and 100% oxygen breathing. Comparison using magnetic resonance imaging delta Po2 mapping. Invest Ophthalmol Vis Sci 1996; 37(10): 2089-2098.
21. Alder VA, Yu DY, Cringle SJ, Su EN. Changes in vitreal oxygen tension distribution in the streptozotocin diabetic rat. Diabetologia 1991; 34(7): 469-476.
22. Stefansson E, Hatchell DL, Fisher BL, Sutherland FS, Machemer R. Panretinal photocoagulation and retinal oxygenation in normal and diabetic cats. Am J Ophthalmol 1986; 101(6): 657-664.
23. Stefansson E, Peterson JI, Wang YH. Intraocular oxygen tension measured with a fiber-optic sensor in normal and diabetic dogs. Am J Physiol 1989; 256 (4 Pt 2): H1127-H1133.
24. Linsenmeier RA, Braun RD, McRipley MA, Padnick LB, Ahmed J, Hatchell DL, McLeod DS, Lutty GA. Retinal hypoxia in long-term diabetic cats. Invest Ophthalmol Vis Sci 1998; 39(9): 1647-1657.
25. Ola MS, Berkich DA, Xu Y, King MT, Gardner TW, Simpson I, LaNoue KF. Analysis of glucose metabolism in diabetic rat retinas. Am J Physiol Endocrinol Metab 2006; 290(6): E1057-E1067.
26. Diederen RM, Starnes CA, Berkowitz BA, Winkler BS. Reexamining the hyperglycemic pseudohypoxia hypothesis of diabetic oculopathy. Invest Ophthalmol Vis Sci 2006; 47(6): 2726-2731.
27. Arteel GE, Thurman RG, Raleigh JA. Reductive metabolism of the hypoxia marker pimonidazole is regulated by oxygen tension independent of the pyridine nucleotide redox state. Eur J Biochem 1998; 253(3): 743-750.
28. de Gooyer TE, Stevenson KA, Humphries P, Simpson DA, Gardiner TA, Stitt AW. Retinopathy is reduced during experimental diabetes in a mouse model of outer retinal degeneration. Invest Ophthalmol Vis Sci 2006; 47(12): 5561-5568.
29. Kowluru R. Retinal metabolic abnormalities in diabetic mouse: comparison with diabetic rat. Curr Eye Res 2002; 24(2): 123-128.
30. Zhang W, Ito Y, Berlin E, Roberts R, Berkowitz BA. Role of hypoxia during normal retinal vessel development and in experimental retinopathy of prematurity. Invest Ophthalmol Vis Sci 2003; 44(7): 3119-3123.
31. Chan-Ling T, Gock B, Stone J. The effect of oxygen on vasoformative cell division. Evidence that 'physiological hypoxia' is the stimulus for normal retinal vasculogenesis. Invest Ophthalmol Vis Sci 1995; 36(7): 1201-1214.
32. Wilson CA, Berkowitz BA, Sato Y, Ando N, Handa JT, de Juan E Jr. Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation. Arch Ophthalmol 1992; 110(8): 1155-1159.
33. Lund-Andersen H. Mechanisms for monitoring changes in retinal status following therapeutic intervention in diabetic retinopathy. Surv Ophthalmol 2002; 47 Suppl 2: S270-S277.
34. Lightman SL, Palestine AG, Rapoport SI, Rechthand E. Quantitative assessment of the permeability of the rat blood-retinal barrier to small water-soluble non-electrolytes. J. Physiol 1987; 389: 483-490.
35. Lightman S, Pinter G, Yuen L, Bradbury M. Permeability changes at blood-retinal barrier in diabetes and effect of aldose reductase inhibition. Am J Physiol 1990; 259 (3 Pt 2): R601-R605.
36. Caspers-velu LE, Wadhwani KC, Rapoport SI, Kador PF. Permeability of the blood-retinal and blood-aqueous barriers in galactose-fed rats. J. Ocul Pharmacol Ther 1995; 11(3): 469-487.
37. Ennis SR. Permeability of the blood-ocular barrier to mannitol and PAH during experimental diabetes. Curr Eye Res 1990; 9(9): 827-838.
38. Ennis SR, Bets AL. Sucrose permeability of the blood-retinal and blood-brain barriers. Effects of diabetes, hypertonicity, and iodate. Invest Ophthalmol Vis Sci 1986; 27(7): 1095-1102.
39. Tornquist P, Alm A, Bill A. Permeability of ocular vessels and transport across the blood-retinal-barrier. Eye 1990; 4 (Pt 2): 303-309.
40. Grimes PA. Carboxyfluorescein distribution in ocular tissues of normal and diabetic rats. Curr Eye Res 1988; 7(10): 981-988.
41. Grimes PA. Fluorescein distribution in retinas of normal and diabetic rats. Exp Eye Res 1985; 41(2): 227-238.
42. Kirber WM, Nichols CW, Grimes PA, Winegrad AI, Laties AM. A permeability defect of the retinal pigment epithelium. Occurrence in early streptozocin diabetes. Arch Ophthalmol 1980; 98(4): 725-728.
43. Maepea O, Karlsson C, Alm A. Blood-ocular and blood-brain barrier function in streptozocin-induced diabetes in rats. Arch Ophthalmol 1984; 102(9): 1366-1369.
44. Wallow IH. Posterior and anterior permeability defects? Morphologic observations on streptozotocin-treated rats. Invest Ophthalmol Vis Sci 1983; 24(9): 1259-1268.
45. Murata T, Nakagawa K, Khalil A, Ishibashi T, Inomata H, Sueishi K. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas. Lab Invest 1996; 74(4): 819-825.
46. Vinores SA, Van Niel E, Swerdloff JL, Campochiaro PA. Electron microscopic immunocytochemical evidence for the mechanism of blood-retinal barrier breakdown in galactosemic rats and its association with aldose reductase expression and inhibition. Exp Eye Res 1993; 57(6): 723-735.
47. Vinores SA, McGehee R, Lee A, Gadegbeku C, Campochiaro PA. Ultrastructural localization of blood-retinal barrier breakdown in diabetic and galactosemic rats. J. Histochem Cytochem 1990; 38(9): 1341-1352.
48. Xu Q, Qaum T, Adamis AP. Sensitive blood-retinal barrier breakdown quantitation using Evans blue. Invest Ophthalmol Vis Sci 2001; 42(3): 789-794.
49. Enea NA, Hollis TM, Kern JA, Gardner TW. Histamine H1 receptors mediate increased blood-retinal barrier permeability in experimental diabetes. Arch Ophthalmol 1989; 107(2): 270-274.
50. Murata T, Ishibashi T, Khalil A, Hata Y, Yoshikawa H, Inomata H. Vascular endothelial growth factor plays a role in hyperpermeability of diabetic retinal vessels. Ophthalmic Res 1995; 27(1): 48-52.
51. Jones CW, Cunha-Vaz JG, Rusin MM. Vitreous fluorophotometry in the alloxan- and streptozocin-treated rat. Arch Ophthalmol 1982; 100(7): 1141-1145.
52. Dallal MM, Chang SW. Evans blue dye in the assessment of permeability-surface are product in perfused rat lungs. J. Appl Physiol 1994; 77(2): 1030-1035.
53. DiMattio J. In vivo use of neutral radiolabelled molecular probes to evaluate blood-ocular barrier integrity in normal and streptozotocin-diabetic rats. Diabetologia 1991; 34(12): 862-867.
54. Antonetti DA, Barber AJ, Khin S, Lieth E, Tarbell JM, Gardner TW. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group. Diabetes 1998; 47(12): 1953-1959.
55. Menzies SA, Hoff JT, Betz AL. Extravasation of albumin in ischaemic brain oedema. Acta Neurochir Suppl (Wien) 1990; 51: 220-222.
56. Schmetterer L, Wolzt M. Ocular blood flow and associated functional deviations in diabetic retinopathy. Diabetologia 1999; 42(4): 387-405.
57. Trick GL, Berkowitz BA. Retinal oxygenation response and retinopathy. Prog Retin Eye Res 2005; 24(2): 259-274.
58. Trick GL, Edwards P, Desai U, Berkowitz BA. Early supernormal retinal oxygenation response in patients with diabetes. Invest Ophthalmol Vis Sci 2006; 47(4): 1612-1619.
59. Braun RD, Linsenmeier RA. Retinal oxygen tension and the electroretinogram during arterial occlusion in the cat. Invest Ophthalmol Vis Sci 1995; 36(3): 523-541.
60. Berkowitz BA, Roberts R, Luan H, Peysakhov J, Knoerzer DL, Connor JR, Hohman TC. Drug intervention can correct subnormal retinal oxygenation response in experimental diabetic retinopathy. Invest Ophthalmol Vis Sci 2005; 46(8): 2954-2960.
61. Yu DY, Cringle SJ, Alder V, Su EN. Intraretinal oxygen distribution in the rat with graded systemic hyperoxia and hypercapnia. Invest Ophthalmol Vis Sci 1999; 40(9): 2082-2087.
62. Anon. Effect of ruboxistaurin in patients with diabetic macular edema: thirty-month results of the randomized PKC-DMES clinical trial. Arch Ophthalmol 2007; 125(3): 318-324.
63. Joussen AM, Poulaki V, Le ML, Koizumi K, Esser C, Janicki H, Schraermeyer U, Kociok N, Fauser S, Kirchhof B, Kern TS, Adamis AP. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J 2004; 18(12): 1450-1452.
64. Kowluru RA, Kern TS, Engerman RL. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. IV. Antioxidant defense system. Free Radic Biol Med 1997; 22(4): 587-592.
65. Tamano H, Enomoto S, Oku N, Takeda A. Preferential uptake of zinc, manganese, and rubidium in rat brain tumor. Nucl Med Biol 2002; 29(4): 505-508.
66. Young TL, Cepko CL. A role for ligand-gated ion channels in rod photoreceptor development. Neuron 2004; 41(6): 867-879.
67. 2+ signaling. Cell Mol Life Sci 2005; 62(21): 2405-2413.
68. Lin YJ, Koretsky AP. Manganese ion enhances T1-weighted MRI during brain activation: an approach to direct imaging of brain function. Magn Reson Med 1997; 38(3): 378-388.
69. Yu X. Wadghiri YZ, Sanes DH, Turnbull DH. In vivo auditory brain mapping in mice with Mn-enhanced MRI. Nat Neurosci 2005; 8(7): 961-968.
70. Berkowitz BA, Roberts R, Penn JS, Gradianu M. High-resolution manganese-enhanced MRI of experimental retinopathy of prematurity. Invest Ophthalmol Vis Sci 2007; 48(10): 4733-4740.
71. Thuen M, Singstad TE, Pedersen TB, Haraldseth O, Berry M, Sandvig A, Brekken C. Manganese-enhanced MRI of the optic visual pathway and optic nerve injury in adult rats. J. Magn Reson Imaging 2005; 22(4): 492-500.
72. Ryu S, Brown SL, Kolozsvary A, Ewing JR, Kim JH. Noninvasive detection of radiation-induced optic neuropathy by manganese-enhanced MRI. Radiat Res 2002; 157(5): 500-505.
73. Hegedus B, Banerjee D, Yeh TH, Rothermich S, Perry A, Rubin JB, Garbow JR, Gutmann DH. Preclinical cancer therapy in a mouse model of neurofibromatosis-1 optic glioma. Cancer Res 2008; 68(5): 1520-1528.
74. Lindsey JD, Scadeng M, Dubowitz DJ, Crowston JG, Weinreb RN. Magnetic resonance imaging of the visual system in vivo: trans-synaptic illumination of V1 and V2 visual cortex. Neuroimage 2007; 34(4): 1619-1626.
75. Skjold A, Amundsen BH, Wiseth R, Stoylen A, Haraldseth O, Larsson HB, Jynge P. Manganese dipyridoxyl-diphosphate (MnDPDP) as a viability marker in patients with myocardial infarction. J. Magn Reson Imaging 2007; 26(3): 720-727.
76. Boretius S, Gadjanski I, Demmer I, Bahr M, Diem R, Michaelis T, Frahm J. MRI of optic neuritis in a rat model. Neuroimage 2008; 41(2): 323-334.
77. Gallez B, Baudelet C, Adline J, Geurts M, Delzenne N. Accumulation of manganese in the brain of mice after intravenous injection of manganese-based contrast agents. Chem Res Toxicol 1997; 10(4): 360-363.
78. Roberts R, Luan H, Berkowitz BA. alpha-lipoic acid corrects late-phase supernormal retinal oxygenation response in experimental diabetic retinopathy. Invest Ophthalmol Vis Sci 2006; 47(9): 4077-4082.
79. Ando N, Sen HA, Berkowitz BA, Wilson CA, de Juan E Jr. Localization and quantitation of blood-retinal barrier breakdown in experimental proliferative vitreoretinopathy. Arch Ophthalmol 1994; 112(1): 117-122.
80. Berkowitz BA, Wilson CA, Tofts PS, Peshock RM. Effect of vitreous fluidity on the measurement of blood-retinal barrier permeability using contrast-enhanced MRI. Magn Reson Med 1994; 31(1): 61-66.
81. Tofts PS, Berkowitz BA. Measurement of capillary permeability from the Gd enhancement curve: a comparison of bolus and constant infusion injection methods. Magn Reson Imaging 1994; 12(1): 81-91.
82. Sen HA, Berkowitz BA, Ando N, de Juan E Jr. In vivo imaging of breakdown of the inner and outer blood-retinal barriers. Invest Ophthalmol Vis Sci 1992; 33(13): 3507-3512.
83. Berkowitz BA, Sato Y, Wilson CA, de Juan E. Blood-retinal barrier breakdown investigated by real-time magnetic resonance imaging after gadolinium-diethylenetriaminepentaacetic acid injection. Invest Ophthalmol Vis Sci 1991; 32(11): 2854-2860.
84. Duong TQ, Ngan SC, Ugurbil K, Kim SG. Functional magnetic resonance imaging of the retina. Invest Ophthalmol Vis Sci 2002; 43(4): 1176-1181.
85. Rucker JC, Biousse V, Mao H, Sandbach J, Constantinidis I, Newman NJ. Detection of lactate in the human vitreous body using proton magnetic resonance spectroscopy. Arch Ophthalmol 2003; 121(6): 909-911.
86. Ngumah QC, Buchthal SD, Dacheux RF. Longitudinal non-invasive proton NMR spectroscopy measurement of vitreous lactate in a rabbit model of ocular hypertension. Exp Eye Res 2006; 83(2): 390-400.
87. Berkowitz BA, Wilson CA. A direct method for investigating vitreous glucose turnover in vivo. Invest Ophthalmol Vis Sci 1993; 34: 1279.
88. Handa JT, Berkowitz BA, Wilson CA, Ando N, Sen HA, Jaffe GJ. Hypoxia precedes the development of experimental preretinal neovascularization. Graefes Arch Clin Exp Ophthalmol 1996; 234(1): 43-46.
89. Metrikin DC, Wilson CA, Berkowitz BA, Lam MK, Wood GK, Peshock RM. Measurement of blood-retinal barrier breakdown in endotoxin-induced endophthalmitis. Invest Ophthalmol Vis Sci 1995; 36(7): 1361-1370.
90. Wilson CA, Berkowitz BA, Funatsu H, Metrikin DC, Harrison DW, Lam MK, Sonkin PL. Blood-retinal barrier breakdown following experimental retinal ischemia and reperfusion. Exp Eye Res 1995; 61(5): 547-557.
91. Braun RD, Gradianu M, Vistisen KS, Roberts RL, Berkowitz BA. Manganese-enhanced MRI of human choroidal melanoma xenografts: Invest Ophthalmol Vis Sci 2007; 48(3): 963-967.
92. Berkowitz BA, Roberts R, Stemmler A, Luan H, Gradianu M. Impaired apparent ion demand in experimental diabetic retinopathy: correction by lipoic acid. Invest Ophthalmol Vis Sci 2007; 48(10): 4753-4758.
93. Berkowitz BA, Ito Y, Kern TS, McDonald C, Hawkins R. Correction of early subnormal superior hemiretinal deltaPO(2) predicts therapeutic efficacy in experimental diabetic retinopathy. Invest Ophthalmol Vis Sci 2001; 42(12): 2964-2969.
94. Roberts R, Luan H, Berkowitz BA. Blocking ET-1 receptors does not correct subnormal retinal oxygenation response in experimental diabetic retinopathy. Invest Ophthalmol Vis Sci 2006; 47(8): 3550-3555.
95. Berkowitz BA, Luan H, Gupta RR, Pacheco D, Seidner A, Roberts R, Liggett J, Knoerzer DL, Connor JR, Du Y, Kern TS, Ito Y. Regulation of the early subnormal retinal oxygenation response in experimental diabetes by inducible nitric oxide synthase. Diabetes 2004; 53(1): 173-178.
96. Luan H, Leitges M, Gupta RR, Pacheco D, Seidner A, Liggett J, Ito Y, Kowluru R, Berkowitz BA. Effect of PKCbeta on retinal oxygenation response in experimental diabetes. Invest Ophthalmol Vis Sci 2004; 45(3): 937-942.
97. Duong TQ, Pardue MP, Thule PT, Olson DE, Cheng H, Nair G, Li Y, Kim M, Zhang X, Shen Q. Layer-specific anatomical, physiological and functional MRI of the retina. NMR Biomed 2008, DOI: 10.1002/nbm.1311
98. Maleki N, Dai W, Alsop DC. Arterial spin labelling methods. Proc Intl Soc Mag Reson Med 2008; 1932.